Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Karina Drake"'
Publikováno v:
Current Psychiatry Reports. 24:503-508
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21b104c53d829f472f76b114cea82b0f
https://doi.org/10.1007/s11920-022-01365-w
https://doi.org/10.1007/s11920-022-01365-w
Publikováno v:
Current psychiatry reportsPapers of particular interest, published recently, have been highlighted as: • Of importance. 24(10)
The goal of this paper is to summarize the evidence for the use of botanical medicines for the treatment of anxiety disorders. We sought to make this review practical for psychiatrists and psychiatric prescribers.In 2018, the Natural Medicines databa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::31f15c2e45b0e722baa224f440b02bff
https://pubmed.ncbi.nlm.nih.gov/36048322
https://pubmed.ncbi.nlm.nih.gov/36048322
Autor:
Sagar V, Parikh, Daniela, Lopez, Jennifer L, Vande Voort, Jose, Rico, Eric, Achtyes, William, Coryell, Andrew, Goddard, Fernando, Goes, John F, Greden, Balwinder, Singh, Adam, Kaplin, Mark A, Frye, Daniel, Maixner, Brendon, Watson, Karina, Drake, Vijay, Tarnal, Patricio, Riva-Posse, William V, Bobo, Bio-K Study Team
Publikováno v:
Psychopharmacol Bull
The efficacy of subanesthetic intravenous ketamine for treatment resistant depression (TRD) has spurred a growth of clinics nationwide that provide this service. Ketamine is an FDA-approved drug as an anesthetic but remains unapproved for psychiatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bdceef9eb6a7543696af128f5c834e0f
https://pubmed.ncbi.nlm.nih.gov/34421148
https://pubmed.ncbi.nlm.nih.gov/34421148
Autor:
Michael I. Casher, Karina Drake
Publikováno v:
Manual of Inpatient Psychiatry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f758f0761f8738e3bb9771531c80b326
https://doi.org/10.1017/9781108656672.007
https://doi.org/10.1017/9781108656672.007
Publikováno v:
Current Psychiatry Reports. 20
To explore the most recent developments in the effective diagnosis and treatment of neuropsychiatric symptoms (NPS) in Alzheimer’s disease (AD). The clinical diagnosis of NPS in AD is facilitated by the use of the Neuropsychiatric Inventory (NPI).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::578ca12be2cf413870ead096674fc438
https://doi.org/10.1007/s11920-018-0978-8
https://doi.org/10.1007/s11920-018-0978-8